trial

DMHI for At-Risk College Students

NCTId NCT06608498
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 50 (actual)
Sponsored by University of Washington
Primary completion 2025-01-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
50 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2024-10-04
Primary completion
2025-01-06
Eligibility
ALL · 18 Years · 30 Years

Interventions & indications

Drugs
SPARK Coping

Sponsors

University of WashingtonLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Ben Buck, PhDPrincipal Investigator

Sites

1 total
Seattle, United States

Facts & assertions

4 sourced
Enrollment
50
Phase
NA
Primary Completion Date
2025-01-06
Status
COMPLETED
relationships
The graph out of here
drug
SPARK Coping
drug
lead_sponsor
University of Washington
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Prodromal Symptoms
indication
Prodromal Symptoms
indication
Psychosis
indication
investigator
Ben Buck, PhD
person